Ureteral Neoplasms

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2021-06-09
Clinical Trial Update: LCI-GU-URO-CRI-001: Crizotinib in Patients With c-MET or RON-Positive Metastatic Urothelial Cancer [Phase 2]
Phase 2 trial of crizotinib in patients with c-MET or RON-positive metastatic urothelial cancer has been terminated; results were posted.